How effective is doxazosin compared with chlorthalidone in the treatment of hypertension?
Koval, P.G.; McDiarmid, T.
Journal of Family Practice 49(7): 597-598
2000
ISSN/ISBN: 0094-3509 PMID: 10923564 Document Number: 523317
Document emailed within 1 workday
Related Documents
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071Angelino, P.F.; Alvino-Demartino, A.; Mappa, R.; Donati, C. 1985: Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 23(9): 501-505
Fagerberg, S.E.; Göransson, K. 1974: A comparative study of spironolactone and chlorthalidone in treatment of hypertension Lakartidningen 71(3): 175-177
Maxwell, M.H.; Garrett, B.N.; Saunders, E.; Schnaper, H. 1987: Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension Clinical Therapeutics 9(4): 380-389
Pessina, A.C. 1995: Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study La Clinica Terapeutica 146(1): 3-12
Ahaneku, J.E.; Taylor, G.O.; Agbedana, E.O. 1998: Influence of baseline values. II: Variations in plasma lipoprotein fractions during doxazosin treatment for hypertension International Journal of Clinical Pharmacology Research 18(4): 165-170
Muiesan, G.; Agabiti-Rosei, E.; Buoninconti, R.; Carotti, A.; Fariello, R.; Innocenti, P.; Toso, M.; Valori, C.; Motolese, M. 1981: A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 19(6): 249-255
de Pasquale, C.; Currò, F.; Amadeo, A. 1978: Importance of the continuity of anti-hypertension treatment in prevention of ischemic cardiovascular diseases: preliminary note. Controlled study of hypertensive patients treated with amiloride associated with hydrochlorothiazide and chlorthalidone Minerva Medica 69(31): 2115-2123
Gratzke, P.; Kirby, R.S. 2000: Doxazosin GITS versus regular doxazosin in benign prostatic hyperplasia. Restoring urine flow and sexual function more easily MMW Fortschritte der Medizin 142(26-27): 40
Jiménez-García, R.; Anegón, M.; Esteban, J.; Carrasco, P.; Apaolaza, I.; Gil, A. 2003: Safety and effectiveness of replacing standard doxazosin with doxazosin in the gastrointestinal therapeutic system (GITS) formulation in elderly hypertensive patients International Journal of Clinical Practice 57(4): 267-272
Gratzke, P.; Kirby, R.S. 2000: Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability Fortschritte der Medizin. Originalien 118(Suppl 2): 83-92
Kreeft, J.H.; Larochelle, P.; Ogilvie, R.I. 1983: Comparison of chlorthalidone and spironolactone in low--renin essential hypertension Canadian Medical Association Journal 128(1): 31-34
Arndts, D.; Doevendans, J.; Arendt, G.; Rippen, G. 1981: Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone Arzneimittel-Forschung 31(11): 1954-1957
Talseth, T.; Westlie, L.; Daae, L. 1990: A long-term study of atenolol and doxazosin in mild and moderate hypertension Journal of Human Hypertension 4(Suppl 3): 39-44
Dominiak, P. 1993: Doxazosin. a postsynaptic alpha 1-adrenergic receptor blocker in therapy of hypertension Der Internist 34(7): 682-687
Hoogenberg, K.; van der Tuin, J. 2002: Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension Nederlands Tijdschrift Voor Geneeskunde 146(44): 2099-2100
Nechwatal, W. 1987: Doxazosin and nitrendipine. a double-blind comparative study in patients with mild to moderate hypertension Fortschritte der Medizin 105(34): 679-682
Bagatin, J.; Sardelić, S.; Rumboldt, Z.; Pavlicević, I.; Pivac, N.; Naranca, M. 1995: The vasodilating effect of chlorthalidone in mild hypertension evaluated by impedance venous plethysmography Lijecnicki Vjesnik 117(1-2): 15-18
Wajngarten, M.; de Moraes, A.V.; Barretto, A.C.; Mady, C.; Martnelli Filho, M.; Dauar, D.; Netto, M.P.; Ebaid, M.; Décourt, L.V. 1980: Behavior of certain echocardiographic variables in patients with uncomplicated borderline arterial hypertension - influence of chlorthalidone and propranolol Revista do Hospital das Clinicas 35(4): 199-204
Holtzman, E.; Rosenthal, T.; Goldbourt, U.; Segal, P. 1984: Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status Israel Journal of Medical Sciences 20(12): 1169-1176